The gene product Murr1 restricts HIV-1 replication in resting CD4 + lymphocytes

Nature

Volumn 426, Issue 6968, 2003, Pages 853-857

  Ganesh, Lakshmanan ^a   Burstein, Ezra ^a,b   Guha Niyogi, Anuradha ^a   Louder, Mark K ^a   Mascola, John R ^a   Klomp, Leo W J ^c   Wijmenga, Cisca ^c   Duckett, Colin S ^b   Nabel, Gary J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CONCENTRATION (PROCESS); COPPER; VIRUSES;

VIRAL REPLICATION;

GENES;

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; GENE PRODUCT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN MURR1; UNCLASSIFIED DRUG;

VIRUS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RNA INTERFERENCE; T LYMPHOCYTE; VIROGENESIS; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS REPLICATION;

CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CYSTEINE ENDOPEPTIDASES; HIV-1; HUMANS; I-KAPPA B PROTEINS; JURKAT CELLS; MULTIENZYME COMPLEXES; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; RNA INTERFERENCE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0346340064     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02171     Document Type: Article

References (31)

1. McDougal, J. S. et al. Cellular tropism of the human retrovirus HTLV-III/LAV I. Role of T cell activation and expression of the T4 antigen. J. Immunol. 138, 3151-3162 (1985).
2. Nabel, G. & Baltimore, D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711-713 (1987).
3. Zack, J. A. et al. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61, 213-222 (1990).
4. Bukrinsky, M. I., Stanwick, T. L., Dempsey, M. P. & Stevenson, M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423-427 (1991).
5. Pomerantz, R. J., Seshamma, T. & Trono, D. Efficient replication of human immunodeficiency virus type 1 requires a threshold concentration of Rev: potential implications for latency. J. Virol. 66, 1809-1813 (1992).
6. Zack, J. A., Haislip, A. M., Krogstad, P. & Chen, I. S. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66, 1717-1725 (1992).
7. Blankson, J. N., Persaud, D. & Siliciano, R. F. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53, 557-593 (2002).
8. van de Sluis, B., Rothuizen, I., Pearson, P. L., van Oost, B. A. & Wijmenga, C. Identification of a new copper metabolism gene by positional cloning in a purebred dog population. Hum. Mol. Genet. 11, 165-173 (2002).
9. Klomp, A. E. M., van de Sluis, B., Klomp, L. W. I. & Wijmenga, C. The ubiquitously expressed Murr1 protein is absent in canine copper toxicosis. J. Hepatol. 39, 703-709 (2003).
10. Hofer-Warbinek, R. et al. Activation of NF-κB by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J. Biol. Chem. 275, 22064-22068 (2000).
11. Richter, B. W. M. & Duckett, C. S. The IAP proteins: caspase inhibitors and beyond. Sci. STKE http://stke.sciencemag.org/cgi/content/full/sigtrans;2000/44/pe1 (2000).
12. Verma, I. M., Stevenson, J. K., Schwarz, E. M., Antwerp, D. V. & Miyamoto, S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 9, 2723-2735 (1995).
13. Huxford, T., Huang, D.-B., Malek, S. & Ghosh, G. The crystal structure of the IκBα/NF-κB complex reveals mechanisms of NF-κB inactivation. Cell 95, 759-770 (1998).
14. Schmid, J. A. et al. Dynamics of NFκB and IκBα studied with green fluorescent protein (GFP) fusion proteins. Investigation of GFP-p65 binding to DNA by fluorescence resonance energy transfer. J. Biol. Chem. 275, 17035-17042 (2000).
15. Hersko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425-479 (1998).
16. Tan, P. et al. Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of IκBα. Mol. Cell 3, 527-533 (1999).
17. Wong, J. K. et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291-1295 (1997).
18. Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295-1300 (1997).
19. Jordan, A., Defechereux, P. & Verdin, E. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 20,1726-1738 (2001).
20. Kao, S. Y., Calman, A. F., Luciw, P. A. & Peterlin, B. M. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330, 489-493 (1987).
21. Adams, M. et al. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc Natl Acad. Sci. USA 91, 3862-3866 (1994).
22. Baldwin, A. S. Jr The transcription factor NF-κB and human disease. J. Clin. Invest. 107, 3-6 (2001).
23. Silverman, N. & Maniatis, T. NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15, 2321-2342 (2001).
24. Ben-Neriah, Y. Regulatory functions of ubiquitination in the immune system. Nature Immunol. 3, 20-26 (2002).
25. Karin, M. & Lin, A. NF-κB at the crossroads of life and death. Nature Immunol. 3, 221-227 (2002).
26. Beg, A. A., Finco, T. S., Nantermet, P. V. & Baldwin, A. S. Jr Tumor necrosis factor and interleukin-I lead to phosphorylation and loss of IkB-α: a mechanism for NF-κB activation. Mol. Cell. Biol. 13, 3301-3310 (1993).
27. Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M. & Karin, M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91, 243-252 (1997).
28. SKP2 targets CDK9 for ubiquitination and degradation by the proteasome. Mol. Cell. Biol. 21, 7956-7970 (2001).
29. Schubert, U. et al. Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl. Acad. Sci. USA 97, 13057-13062 (2000).
30. Mascola, I. R. et al. Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells. J. Virol. 76, 4810-4821 (2002).
31. Yu, X. et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cu15-SCF complex. Science 302, 1056-1060 (2003).